Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Swiss activists plan 'occupy' protest at Novartis chair's house
Fierce Pharma
Thursday, October 27, 2011 - 1:31pm
tags:
Novartis, Daniel Vasella, activists
Pfizer Inc. Third Quarter Earnings on the Horizon
Yahoo/Wall St. Cheat Sheet
Thursday, October 27, 2011 - 1:29pm
tags:
Pfizer, earnings
Bayer Third-Quarter Profit More Than Doubles on Demand in Emerging Markets
Bloomberg
Thursday, October 27, 2011 - 11:44am
tags:
Bayer AG, earnings
Elan Posts Profit on Tysabri Gains, Sale of Technology Unit
Bloomberg
Thursday, October 27, 2011 - 11:40am
tags:
Elan, earnings, Tysabri
Novo Nordisk Q3 net profit rises 17 percent
Yahoo/AP
Thursday, October 27, 2011 - 11:34am
tags:
Novo Nordisk, earnings
Cubist's Adolor Acquisition Aligns Well With Its Own Skill Set
Seeking Alpha
Thursday, October 27, 2011 - 11:33am
tags:
Adolor, Cubist, M&A
Dr. Reddy's Continues to Grow
Yahoo/Zacks.com
Thursday, October 27, 2011 - 11:32am
tags:
Dr Reddy's, earnings
New job opportunities emerging in Big Pharma
Fierce Pharma
Thursday, October 27, 2011 - 11:20am
tags:
layoffs
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thursday, October 27, 2011 - 11:12am
tags:
breast cancer, physicians, Avastin, Roche, Taxol
Gardasil Policy May Grow Coverage Without Reversing Sales Slide
Bloomberg Businessweek
Thursday, October 27, 2011 - 11:11am
tags:
HPV, Merck, Gardasil
Eli Lilly Is Overvalued, Pfizer More Attractive
Seeking Alpha
Thursday, October 27, 2011 - 11:07am
tags:
Eli Lilly, Pfizer, Sanofi, GSK
Pfizer's blockbuster pneumonia vaccine Prevnar 13 gets EU approval for adults 50 and older
Yahoo/AP
Thursday, October 27, 2011 - 11:06am
tags:
Pfizer, Prevnar 13, vaccine, Europe, pneumonia
AstraZeneca Q3 net profit boosted by disposal
Yahoo/AP
Thursday, October 27, 2011 - 9:29am
tags:
earnings, AstraZeneca
Bristol-Myers Tops Third-Quarter Profit Estimate
Bloomberg
Thursday, October 27, 2011 - 8:20am
tags:
earnings, Bristol-Myers Squibb
Another Round Of Milestone News Solidifies Ampio's Pipeline Potential
Seeking Alpha
Wednesday, October 26, 2011 - 6:14pm
tags:
Ampio Pharmaceuticals, Ampion, Daewoong Pharmaceuticals, Optina, diabetic macular edema, Zertane, premature ejaculation, osteoarthritis
Earnings Preview: Merck reports on third quarter
Yahoo/AP
Wednesday, October 26, 2011 - 6:12pm
tags:
earnings, Merck
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wednesday, October 26, 2011 - 6:12pm
tags:
Bristol-Myers Squibb, diabetes, FDA, AstraZeneca, Dapagliflozin
Biotech 2011: Teva, Merck directors share views of biopharma industry
Med City
Wednesday, October 26, 2011 - 11:07am
tags:
Teva Pharmaceuticals, Merck, Biotech 2011
Mylan says CEO Coury to step down; shares rise
Reuters
Wednesday, October 26, 2011 - 11:04am
tags:
Mylan, Pharma CEOs, Robert Coury
Merck KGaA Advances Most Since 2009 as Profit Beats Estimates
Bloomberg
Wednesday, October 26, 2011 - 10:41am
tags:
Merck KGaA, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.